Cimzia®

Cimzia (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s Disease Rheumatoid Arthritis (RA) Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondylarthritis.
For more information, visit the patient website for this drug.

Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

UCB Group

CLASS:
Biologics (tumor necrosis factor blocker)
WHAT IT TREATS:
  • Rheumatoid Arthritis (RA)
  • Psoriatic arthritis
  • Ankylosing Spondylitis (AS)
  • Crohn’s Disease
  • Plaque Psoriasis
  • Non-radiographic axial spondyloarthritis
PRESCRIBED BY:
  • Rheumatologists
  • Gastroenterologists
  • Dermatologists
HOW ADMINISTERED:
Subcutaneous injection
FREQUENCY:

Initial dose then two weeks later then 4 weeks and every 4 weeks after

Length of infusion:
About 15 minutes